Valuation: Amgen Inc.

Market Cap 223B 199B 186B 168B 317B 21,186B 320B 2,226B 872B 11,018B 838B 820B 35,357B P/E 2026 *
26.2x
P/E 2027 * 23.4x
Enterprise Value 265B 236B 220B 200B 376B 25,112B 379B 2,639B 1,033B 13,060B 994B 972B 41,908B EV / Sales 2026 *
6.79x
EV / Sales 2027 * 6.41x
Free-Float
99.77%
Yield 2026 *
2.44%
Yield 2027 * 2.58%
1 day-0.94%
1 week+2.54%
Current month-2.06%
1 month+9.41%
3 months+14.53%
6 months+18.01%
Current year+26.13%
1 week 400.06
Extreme 400.06
420.35
1 month 374.46
Extreme 374.46
426.59
Current year 318.21
Extreme 318.21
447.03
1 year 288
Extreme 288
447.03
3 years 249.7
Extreme 249.7001
447.03
5 years 198.64
Extreme 198.64
447.03
10 years 133.64
Extreme 133.64
447.03
Manager TitleAgeSince
Chief Executive Officer 63 30/04/2012
Director of Finance/CFO 62 12/05/2010
Chief Tech/Sci/R&D Officer 57 31/05/2023
Director TitleAgeSince
Chairman 63 31/12/2012
Director/Board Member 65 31/12/2011
Director/Board Member 71 31/12/2011
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Other

Chief Financial Officer

34,061 0.0063%
13/08/26 Exercice

Executive/Senior Manager

3,756 0.0007%
07/08/26 Free

Director

85 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.13%+2.54%+41.19%+45.32% 223B
-1.36%+0.78%+42.36%+91.48% 1,040B
-5.73%-2.42%+30.23%+58.50% 599B
-2.40%+2.88%+19.13%+85.43% 485B
-2.39%+0.03%+65.67%+36.51% 350B
+0.90%+0.83%+26.83%+43.96% 345B
+1.19%+0.58%+16.03%+38.44% 272B
+0.59%-1.79%-6.09%+9.02% 244B
-1.67%+2.56%+25.13%+90.50% 183B
-1.23%-0.14%-29.70%-64.13% 170B
Average +0.46%+2.59%+23.08%+43.50% 391.28B
Weighted average by Cap. +0.66%+2.40%+29.48%+58.28%

Financials

2026 *2027 *
Net sales 38.97B 34.81B 32.45B 29.42B 55.36B 3,699B 55.8B 389B 152B 1,924B 146B 143B 6,173B 40.38B 36.07B 33.62B 30.48B 57.36B 3,833B 57.81B 403B 158B 1,993B 152B 148B 6,396B
Net income 8.54B 7.63B 7.11B 6.45B 12.13B 811B 12.23B 85.18B 33.35B 422B 32.07B 31.37B 1,353B 9.43B 8.42B 7.85B 7.12B 13.39B 895B 13.5B 94.02B 36.81B 465B 35.4B 34.62B 1,493B
Net Debt 41.36B 36.94B 34.44B 31.22B 58.75B 3,926B 59.21B 413B 161B 2,042B 155B 152B 6,551B 35.48B 31.69B 29.54B 26.78B 50.4B 3,368B 50.8B 354B 139B 1,751B 133B 130B 5,620B
Projected Income Statement - Annual - Amgen Inc.
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
13/10/26 US$412.84 -1.13% 2,319,612
12/10/26 US$417.57 +0.65% 1,720,680
09/10/26 US$414.87 +1.82% 2,553,179
08/10/26 US$407.44 -1.37% 2,378,286
07/10/26 US$413.08 +2.60% 2,237,193
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Amgen Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
34
Last Close Price
412.84USD
Average target price
394.77USD
Spread / Average Target
-4.38%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Amgen Inc.
  1. Stock Market
  2. Stocks
  3. AMGN Stock